August 28, 2017 / 8:02 PM / in 10 months

Drugmakers renew call for court to dismiss Taxotere MDL complaint

Drugmakers have renewed their call for a federal court to dismiss a complaint by some 1,500 women in a multidistrict litigation over breast cancer drug Taxotere’s risk of permanent hair loss, arguing their complaint lacks factual allegations.

Defendants, including Sanofi Inc, Sandoz Inc, Pfizer Inc and Accord Healthcare Inc, on Friday filed a reply to the response their motion first filed in May urging the U.S. District Court for the Eastern District of Louisiana, which is overseeing the MDL, to toss the women’s master complaint.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below